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The more men by whom a woman has children, the more diverse will be the foetal antigens of paternal origin introduced into her
bloodstream, and we investigated whether this has an impact on subsequent cancer risks. By using population registries we identified
64704 women who had children with at least two different partners from 1973 to 1996 in Denmark. We compared their cancer
incidence with that of women who during the same time period had at least two births with no indication of partner change, adjusting
for age, parity, socioeconomic factors and residence. The overall cancer incidence was more than 50% higher in women with two or
more partners. Women having children with multiple partners had a higher incidence of cancer of the cervix and corpus uteri, a lower
incidence of melanoma but a similar incidence of breast and ovarian cancer. Uncontrolled differences in lifestyle factors may explain
the higher cancer risk associated with having multiple partners. The strong protective effect for melanoma was unexpected and
deserves further study.
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A protective effect of pregnancy on cancer is best documented for
breast cancer (Rossing et al, 1996; Lambe et al, 2001) and ovarian
cancer (Mockett et al, 2000). Other studies suggest a similar effect
on colorectal (Talamini et al, 1998) and uterus cancers (Hinkula
et al, 2002).
Associations with parity may be caused by pregnancy-induced
hormonal changes, but could also have an immunological basis if
women are immunised by the antigens of their fetuses (Janerich,
1980). Certain studies have provided evidence of immunization to
antigens found in breast, ovarian and endometrial cancer cells
(Janerich, 2001, 1994). Sera from multiparous women have been
shown to react against antigens of ovarian cancer, in contrast to
that from healthy nulliparous women. Foetal antigens, perhaps of
parental origin, may protect against cancer (Shields et al, 1997). If
so, such cancers should show some correlation with the number of
pregnancies as well as with the number of different fathers of these
pregnancies. Each new pregnancy results in an expression of new
paternal genes, but a change of partner increases the genetic
variation.
A reproductive history may, on the other hand, correlate with
disease due to confounding. A level of health is required to carry a
pregnancy to term (the ‘healthy pregnancy effect’), although we
expect this to have only a limited effect on cancer risk.
We examined if having pregnancies with multiple partners
influences the risk of some of the commonest cancers.
MATERIAL AND METHODS
We conducted a historical follow-up study using data from the
following population based registries: the Fertility Database, the
Prevention Registry (each a combination of several registers), the
National Hospital Discharge Registry, the Cause of Death Registry
and the Cancer Registry. All the data for this study are located at
Statistics Denmark or at the National Board of Health.
By means of the above-mentioned registers we identified a
cohort comprising all (64704) women with Danish citizenship who
had had at least two births by at least two different men, and whose
second birth took place between 1973 and 1996: the exposed
cohort. We then selected a random sample of 100000 women from
the population of women with at least two children and who had
their index birth (second birth or later) after 1973, as in the
exposed cohort. Among these we selected the 86624 women for
whom there was no indication of a change of partner: the
unexposed cohort. More details on the study population are
provided elsewhere (Olsen et al, 2003).
These two cohorts were then linked to the cancer register and to
the Population Register to obtain information on cancer incidence,
death, emigration, women’s education, social status, residence and
occupation.
Incident diagnoses of cancer were extracted from the Cancer
Register where they are coded according to the International
Classification of Diseases (ICD-7th Revision). Linkage was based
upon the woman’s civil personal registration number (CPR), since
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We analysed data using Poisson regression models. Exposure
started at the first birth with a father different from the one
registered at the previous birth(s). We considered women
‘exposed’ if they had at least one child by a different partner and
if at least two different identifiable fathers were registered. Women
who had a missing identifier for the father (2%) and no indication
of a different father in any of the pregnancies were considered
unexposed. Follow-up ended when cancer, death, or emigration
occurred, or at the end of 1997 (when follow-up ended), whichever
came first.
Missing data on social factors were divided into two categories.
One consisted of unreported actual missing values (a), while the
other consisted of values from years that lacked a classification, or
changes to the classification over time (b). The cohorts were
stratified by parity for which incidence rates over time are
estimated and adjusted for potential confounders: parity (2, 3, 4 or
more); number of partners (1, 2, 3 or more); current maternal age
four age groups o25, 25–34, 35–44, 445 years); calendar period
(1973–1980, 1981–1985, 1986–1990, X1991); time since latest
pregnancy (up to 10 years, more than 10 years); place of residence
(Copenhagen; Aarhus, Odense; Aalborg; all other places; missing
[a]; missing [b]); social status (self-employed, assisting spouses;
high and medium workers; skilled workers; unskilled workers;
unemployed, outside work; missing [a], missing [b]); education
(basic school; high school; missing [a]; missing [b]); and 9)
occupation (production industry; primary services; public and
personal services; missing [a]; missing [b]).
If data were missing for the socioeconomic variables (people out
of the workforce had no classification in some time periods), we
used information from a previous year down to 1979. In the
present analyses, missing data were kept in the analyses as a
separate category, but all analyses were also performed after
excluding subjects with missing data on social factors in the period
1973–1979. Analyses were performed using Poisson regressions in
SAS and STATA software.
RESULTS
Table 1 shows details of the person years of observation and cancer
observed. Altogether, 4173 events of cancer occurred in the cohort
of women with two or more partners, while 4393 events were
recorded among unexposed women.
As expected from their social profile, women with multiple
partners had a higher risk of cancer of the cervix, but they also
showed a higher incidence of cancer of the corpus uteri (Table 2).
The relative risks of breast and ovarian cancer were less than one,
but confidence limits included unity. For breast cancer the crude
Table 1 Distribution of person years (PYs) according to potential confounders in the two cohorts
One partner Two+ partners
Variables Total PYs No. of cancer cases IR per1000 PYs Total PYs No. of cancer cases IR per 1000 PYs
Age during follow-up
o25 34048.0 127 3.73 24210.3 176 7.27
25–34 468241.1 1893 4.04 267043.9 2259 8.46
35–44 407856.8 1798 4.41 241769.9 1557 6.44
445 35837.9 575 6.70 30031.1 181 6.02
Place of residence
Copenhagen 52699.2 242 4.59 52708.3 346 6.56
Aarhus, Odense, Aalborg 85319.9 513 5.38 60265.1 559 9.28
All other places 755255.9 3322 4.40 436016.6 3203 7.35
Missing (a) 23563.2 87 3.69 4933.0 19 2.46
Missing (b) 69145.6 229 3.31 9192.1 46 3.75
Education
Basic school 440434.2 2069 4.70 384028.2 2964 7.72
High school 160407.7 659 4.11 69227.4 482 6.96
Missing (a) 1058.5 2 1.89 1376.6 9 6.54
Missing (b) 394083.5 1663 4.22 108482.9 718 6.62
Socioeconomic status
Self-employed assisting spouses 28454.4 137 4.65 13952.6 100 7.17
High/medium ranked workers 498394.9 2176 4.37 216828.7 1610 7.10
Skilled workers 21969.1 121 5.51 16292.5 151 9.27
Unskilled workers 189255.6 894 4.72 163084.6 1269 7.78
Outside work, unemployed 76164.9 372 4.88 110456.4 869 7.87
Missing (a) 53301.5 211 3.96 14330.3 82 5.72
Missing (b) 127443.5 482 3.78 18170.1 92 5.06
Occupation
Production industry 132429.8 607 4.58 94382.1 718 7.61
Primary services 188050.4 826 4.39 113426.7 884 7.79
Public/personal services 459256.6 2128 4.63 291978.8 2151 7.37
Missing: (a) 88843.0 350 3.94 45184.0 328 7.26
Missing (b) 127403.9 482 3.78 18143.6 92 5.07
Total 995984.0 4393 4.41 563115.0 4173 7.41
aUnreported
bLack of classification or modified classification.
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parity and social factors reduced the effect and a statistically
significant protective effect of having children by more than one
partner was only seen for melanoma.
The parity specific partner effects are displayed in greater detail
in Table 3: no ‘dose–response’ effect with number of partners is
shown for any of the cancers under study, including melanoma.
Malignant melanoma showed a nonsignificant association with
parity, the adjusted rate ratio for parity being 1.04 (0.73–1.49),
compared women with parity 2, and the rate ratio for parity 4 or
higher was 0.65 (0.31, 1.37).
The effect of time interval since having a child by a different
partner is shown in Table 4: no significant change in relative
incidence rates was found for any cancer.
As breast cancers with an early onset may have a different
aetiology than those with a later onset, we estimated the relative
risks separately for women prior to 45 years of age and for women
aged 46 years or older. When adjusted only for parity, both
Table 2 Relative risk of specific cancers and cancers in general for women who have had children with different fathers
One partner Two+ partners
Cancer site Cases Cases RR
a CI RR
b 95% CI
Breast
c 624 256 0.69 0.80 0.81
d 0.77–1.07
Ovarian
e 101 45 0.75 1.08 0.88 0.60–1.28
Cervix
f 2783 3470 2.21 2.32 2.04 1.93–2.15
Uterus and corpus uteri
g,h 43 38 1.49 2.37 1.84 1.14–2.96
Melanoma
i 179 66 0.62 0.83 0.65 0.48–0.88
Lung
j 50 34 1.15 1.81 1.45 0.89–2.36
Colon and rectum
k 74 28 0.64 1.00 0.85 0.52–1.36
The rest of neoplasms
l 663 342 0.87 1.00 1.00 0.87–1.15
All cancers 4393 4173 1.68 1.75 1.66 1.59–1.74
aUnadjusted.
bAdjusted for age, parity, time since latest pregnancy, place of residence, education, socioeconomic status, occupation.
cICD7: 170, 470, 570, 670, 770, 870, 970.
dAs
in footnote b, plus adjustment for age at first delivery.
eICD7: 175, 475, 575, 975.
fICD7: 171, 471, 571, 771, 971.
gICD7: 173, 473, 573, 873, 973.
hICD7: 172, 472, 572, 872, 972.
iICD7: 190, 590, 690, 990.
jICD7: 162, 462.
kICD7: 153, 253, 453, 553.
lICD7: the rest.
Table 3 Adjusted incidence rate ratios
a for the main cancer groups according to parity and number of partners. The reference category is that of women
of parity 2 with one partner
Parity 2 Parity 3 Parity 4+
Partners Partners Partners
2232 3 +
Cancer site RR CI 95% RR CI 95% RR CI 95% RR CI 95% RR CI 95%
Breast
b 0.99 0.79–1.24 0.84 0.63–1.12 1.01 0.60–1.69 0.49 0.26–0.90 0.74 0.33–1.65
Ovary 1.23 0.77–1.96 0.57 0.27–1.21 0.53 0.12–2.29 0.43 0.11–1.70 0.40 0.05–3.39
Cervix 2.00 1.87–2.13 2.23 2.00–2.49 2.75 2.36–3.20 0.97 0.76–1.25 2.06 1.60–2.65
Uterus and corpus uteri 2.38 1.32–4.29 1.70 0.67–4.30 0.96 0.12–7.80 0.53 0.09–3.20 0.58 0.06–6.02
Melanoma 0.70 0.47–1.03 0.68 0.40–1.15 0.51 0.15–1.66 0.22 0.05–1.06 0.56 0.11–2.83
Lung 1.63 0.87–3.06 1.72 0.69–4.27 2.54 0.78–8.29 NA
c — 0.82 0.14–4.72
Colon and rectum 0.85 0.43–1.66 0.92 0.42–2.01 0.72 0.22–4.24 0.35 0.23–2.06 1.21 0.21–6.91
aAdjusted for age, time since latest pregnancy, place of residence, education, socioeconomic status and occupation.
bAdjusted as in footnote
a plus age at first delivery.
cThere
were no cases among women with two partners.
Table 4 Relative incidence rate ratio for the main cancer grounds
a by time since last pregnancy for women who had children with two or more partners
Time since latest pregnancy
0–9 years 10+ years
Cancer site RR 95% CI RR 95% CI
Breast 0.92 0.72–1.15 0.87 0.68–1.11
Ovary 0.76 0.45–1.23 1.12 0.63–1.98
Cervix 2.08 1.96–2.21 1.79 1.57–2.04
Uterus and corpus uteri 1.85 1.05–3.27 1.66 0.69–4.00
Melanoma 0.63 0.44–0.89 0.75 0.42–1.34
Lung 1.41 0.68–2.91 1.44 0.75–2.77
Colon and rectum 0.89 0.46–1.71 0.81 0.40–1.63
aAdjusted for parity, age at first delivery, age, time since latest pregnancy, place of residence, education, socioeconomic status, occupation, reference group, women with two or
more children with the same partner.
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(95% CI: 0.67–0.95) for women below 46 years and RR¼0.68 (95%
CI: 0.49–0.95) for older women). When age, age at first delivery,
place of residence, education, socioeconomic status and occupa-
tion were included in the model, however, there was no significant
reduction among younger women (RR¼0.94 (95% CI: 0.78–1.14))
and only a nonsignificant decrease remained among older women
(RR¼0.72 (95% CI: 0.50–1.03)) (raw data not shown).
DISCUSSION
This study did not provide strong support for the hypothesis that
having children by different partners reduces the risk of breast or
ovarian cancer (Janerich, 1980, 1994; Shields et al, 1997; Talamini
et al, 1998; Lambe et al, 2001). We did see a statistically significant
lower relative risk for breast cancer in the crude estimate, but the
significance disappeared after adjustment. We have previously
shown (Olsen et al, 2003) that adjustment for confounders is
important. Previous findings on a reduced risk of breast cancer
among women having children by different partners may thus
have been subject to residual confounding (Janerich, 1980, 1994;
Lambe et al, 2001).
We do not believe that the foetal antigen hypothesis explains the
higher risk of cancer of the cervix. Rather the excess risk probably
reflects confounding by lifestyle factors such as sexual habits.
The lower risk of melanoma related to two or more partners is
novel and of interest because residual confounders would probably
bias the effect measures towards higher values for this cancer. The
result was unexpected, but rather strong. Melanoma is a common
cancer in populations with fair skin and frequent exposure to
sunlight. Two high-risk susceptibility genes have been identified
(CDKN2A and CDK4) and gene–environment interactions may
occur at several steps in cancer development (MacKie, 2002).
Foetal antigens could in principle modify these gene–environ-
mental interactions in different ways and if such a mechanism is
important, the observed correlation with parity would be
predicted.
The study has strengths as well as weaknesses. The strongest
features lie in its population-based design with complete follow-
up, reliable data on cancer incidence and reproduction, and
independently reported paternal identity for live born children.
We also had data on sociodemographic conditions of potential
importance. All data were recorded independently of the study
hypothesis, which might otherwise produce differential misclassi-
fication.
Without access to the participants we have, on the other hand,
no possibility of verifying data on paternity and we have no data
on pregnancies that ended with foetal loss. Our data refers to the
putative biological father in official statistics but anecdotal
evidence suggests that this may be in error in 1–10% of the cases.
Misclassification of fathers may bias the effect measure for
malignant melanoma, though we consider the magnitude of bias
to be small.
If the foetal antigen hypothesis is true, the effect on parity level
and number of partners is likely to be small. Although we included
all women with two or more births by different partners into the
study, our power to detect a small effect was limited as indicated
by the wide confidence limits. It would be of interest to have data
with longer follow-up time.
We found a protective effect of parity of having children with
different men for malignant melanoma. Whether transmission of
foetal cells to the mother’s blood stream during pregnancy plays a
role for this finding needs further studies.
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